Protection offered by COVID-19 vaccines wanes rapidly in people with obesity Dr. Kamal Kant Kohli13 May 2023 9:15 AM ISTUK: COVID-19 vaccine-induced humoral immunity declines more rapidly in individuals with severe obesity compared to those with normal weight,...
Salt substitute use not salt reduction key to BP lowering and CVD prevention in elderly: DECIDE trial Medha Baranwal10 May 2023 10:45 AM ISTChina: The use of potassium-based salt substitutes rather than efforts to restrict salt supply may achieve blood pressure (BP) lowering in older...
Suboptimal poor diet responsible for 7 of every 10 cases of type 2 diabetes globally Dr. Kamal Kant Kohli19 April 2023 8:00 PM ISTUSA: In 2018, seven in ten (70.3% or 14.1 million) new cases of type 2 diabetes globally were attributable to suboptimal intake of 11 dietary factors,...
Nonstatin therapy obicetrapib promising for addressing unmet medical needs for high CV risk patients Medha Baranwal12 April 2023 9:45 AM ISTNetherlands: CETP inhibitor drug obicetrapib has the potential to address the unmet medical need for patients at high cardiovascular risk, a recent...
Novel immunotherapy agent safe, shows promise against high-risk prostate cancers Dr. Kamal Kant Kohli11 April 2023 8:00 PM ISTA new drug, a monoclonal antibody known as enoblituzumab, is safe in men with aggressive prostate cancer and may induce clinical activity against...
Novel immunotherapy delivery approach benefits some melanoma patients with leptomeningeal disease Dr. Kamal Kant Kohli10 April 2023 2:00 AM ISTA novel approach to administer intrathecal (IT) immunotherapy (directly into the spinal fluid) and intravenous (IV) immunotherapy was safe and...
Medical Bulletin 8/April/2023 Isra Zaman8 April 2023 4:45 PM ISTHere are the top medical news for the day:Study finds spread of COVID-19 in households to be linked to virus on hands and surfacesA new Imperial...
Intermittent fasting could help lower chances of developing type 2 diabetes Dr. Kamal Kant Kohli8 April 2023 11:15 AM ISTResearchers from the University of Adelaide and South Australian Health and Medical Research Institute (SAHMRI) have found in a new study that...
New immunotherapy agent safe and promising against high-risk prostate cancers Isra Zaman8 April 2023 9:15 AM ISTEnoblituzumab, a monoclonal antibody drug works by binding to a protein called B7-H3 that is overexpressed on prostate cancer cells and believed to...
Healthy microbiome could prevent severe infections in ICU Dr. Kamal Kant Kohli6 April 2023 9:00 AM ISTCanada: A recent study published in Nature Medicine found that patients who experienced an abnormal increase in the growth of this common bacteria...
Medical Bulletin 5/April/2023 Isra Zaman5 April 2023 3:00 PM ISTHere are the top medical news for the day:Narrow opportunity to address a rare disease linked to autism, schizophrenia identifiedIn DiGeorge syndrome,...
Lorlatinib is safe and effective for patients with ALK-driven relapsed/refractory high-risk neuroblastoma, research shows Isra Zaman5 April 2023 9:30 AM ISTNeuroblastoma is an aggressive pediatric cancer that develops from early nerve cells, often appearing as a solid tumor in the chest or abdomen. The...
